$CRH

CRH To Acquire Arcosa For $150/share, Arcosa Up In Pre-market

CRH plc agreed to acquire Arcosa, Inc. for $150 per share in cash, valuing Arcosa at about $8.5 billion and implying a 25% premium to its 60-day VWAP as of June 18, according to CRH. CRH expects $175 million in annual run-rate cost synergies by year three and accretion within 12 months after closing, targeted for Q1 2027.

Original reporting
Published Jun 22, 2026, 3:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 22, 2026, 3:58 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CRH To Acquire Arcosa For $150/share, Arcosa Up In Pre-market — source image
Decision brief

The 30-second read

$CRHBullishHigh
01

Why it matters

The disclosed premium, valuation (~$8.5B), synergy target ($175M run-rate by year three), and expected close (Q1 2027) create a clear framework for deal-spread and execution-risk trading.

02

Market read

A fresh, fully specified M&A bid typically drives immediate repricing in the target and deal-spread trading in the acquirer.

03

What to watch

Financing structure, antitrust/regulatory timing, and potential for competing bids are not discussed but are key drivers of deal certainty and spread behavior.

Relevance 9/10Novelty 9/10Timing: pre-market today after CRH announced the $150/share cash acquisition of Arcosa

Background

CRH (building materials) announced an agreement to buy Arcosa (infrastructure-related products) for $150/share cash.

Company-level read

Ticker impact

$CRHBullishHigh confidence
Context

CRH agreed to acquire Arcosa for $150/share in cash, with $175M run-rate synergies and expected Q1 2027 close.

Expected impact

Near-term: support from deal premium and synergy narrative; volatility around regulatory/financing and integration assumptions.

Evidence & confidence

The article discloses the transaction price, implied premium, synergy amount, and timing, which are direct inputs to deal valuation and risk.

$ACABullishHigh confidence
Context

Arcosa is the acquisition target, offered $150/share cash, implying a 25% premium and lifting shares ~7% pre-market.

Expected impact

Near-term: upside capped by offer price with typical deal-spread compression; downside risk if terms face hurdles.

Evidence & confidence

The article provides the offer price, premium basis, and immediate pre-market reaction—core determinants of target valuation.

Market effects

Signals consolidation in U.S. aggregates/construction products and may reset expectations for M&A premiums and synergy benchmarks.

Could increase competitive pressure in U.S. infrastructure materials supply chains where Arcosa has quarries, asphalt plants, and terminals.

Large cross-border-style deal (CRH acquiring U.S. assets) can influence global building-materials M&A sentiment and financing conditions.

Counterpoint

Synergy and accretion claims may be optimistic; deal spreads can widen if integration complexity or regulatory review increases.

Key entities

  • CRH plc

    Agreed to acquire Arcosa for $150/share cash; expects $175M run-rate synergies by year three.

  • Arcosa, Inc.

    Offered $150/share cash; pre-market shares up ~7% on the bid.

Related articles

$CRHMed

Can CRH Gain From Its $8.5 Billion Arcosa Deal Despite Financing Risk?

CRH plans to acquire Arcosa for about $8.5B, with closing expected in Q1 2027 subject to approvals. The deal would add about 35M tons of annual aggregates, targeting over 265M tons U.S. production, and add energy infrastructure exposure. CRH targets $175M annual cost synergies by year three and says the deal should be accretive within 12 months, but notes higher financing and integration risk.

$ACAMed

Arcosa, Inc. (ACA): Results of Operations and Financial Condition

Arcosa, Inc. (ACA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exh991earningsrelease63020.htm EX-99.1 Document Exhibit 99.1 News Release FOR IMMEDIATE RELEASE Arcosa, Inc. Announces Second Quarter 2026 Results DALLAS, Texas - ARCOSA, Inc. - August 5, 2026: Arcosa, Inc. (NYSE: ACA) (“Arcosa,” the “Company,” “We,” or “Our”), a provid

$CRHMedAI 8/10

CRH reports stronger 2Q26 earnings and reaffirms outlook

CRH reported 2Q26 revenues of US$10.8bn, up 6% year over year, and net income up 13% to US$1.5bn. Adjusted EBITDA rose 7% to US$2.6bn, with margins improving. CRH completed three non-core divestments and invested US$1.4bn in 17 acquisitions YTD, and agreed to buy Arcosa for US$8.5bn. It reaffirmed 2026 guidance: net income US$3.9-4.1bn, adjusted EBITDA US$8.1-8.5bn, EPS US$5.60-6.05.

$CRHMedAI 8/10

CRH's second quarter revenues up on pricing and demand

CRH reported Q2 2026 revenues up 6% to $10.8 billion, net income up 13% to $1.5 billion, adjusted EBITDA up 7% to $2.6 billion, and diluted EPS up 14% to $2.21, citing pricing momentum, demand, and acquisitions. The company reaffirmed full-year guidance and completed $1.1 billion of acquisitions and $1.7 billion of net divestiture proceeds.

$CRHHigh

CRH PUBLIC LTD CO (CRH): Results of Operations and Financial Condition

CRH PUBLIC LTD CO (CRH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q2resultsannouncement2026.htm EX-99.1 Document Exhibit 99.1 CRH Reports Second Quarter 2026 Results • Strong quarter driven by good commercial management, favorable underlying demand and contributions from acquisitions • Increases in revenues, profits and margins reflec